TABLE 2

Effect of preincubation on inhibition of P450 activity by cannabinoids and THC metabolites in microsomes from CYP450-overexpressing cell lines

THC11-OH-THCTHC-COO-GlucCBDCBN
Enzyme(−)a(+)bShiftc(−)(+)Shift(−)(+)Shift(−)(+)Shift(−)(+)Shift
CYP1A22.7 ± 1.01.8 ± 0.551.4 ± 0.12NAdNA2.1 ± 0.251.8 ± 0.311.2 ± 0.20NA
CYP3A4NANANA3.1 ± 1.22.0 ± 1.11.1 ± 0.077NA
CYP2B619 ± 5.118 ± 5.01.1 ± 0.0497.3 ± 1.06.1 ± 1.01.2 ± 0.0945.1 ± 1.64.1 ± 1.01.4 ± 0.161.9 ± 0.661.3 ± 0.451.3 ± 0.0482.1 ± 0.832.0 ± 0.701.1 ± 0.061
CYP2C93.4 ± 2.32.3 ± 1.71.4 ± 0.173.2 ± 0.612.2 ± 0.591.4 ± 0.1815 ± 2.415 ± 2.71.0 ± 0.0442.2 ± 1.21.8 ± 0.851.2 ± 0.123.0 ± 2.22.7 ± 2.11.1 ± 0.11
CYP2C193.2 ± 2.52.5 ± 1.81.3 ± 0.13NANA2.5 ± 1.52.3 ± 1.31.1 ± 0.074NA
CYP2D613 ± 0.6710 ± 0.921.3 ± 0.0682.9 ± 0.862.1 ± 0.491.3 ± 0.148.1 ± 1.16.4 ± 2.51.4 ± 0.512.9 ± 1.12.0 ± 0.761.5 ± 0.33NA
CYP2E1NANANA1.1 ± 0.660.9 ± 0.401.2 ± 0.200.87 ± 0.150.73 ± 0.211.2 ± 0.16
  • a(−), IC50 ± S.D. (µM) value of three experiments with 30-min preincubation of test cannabinoid with enzyme without NADPH.

  • b(+), IC50 ± S.D. (µM) value of three experiments with 30-min preincubation of test cannabinoid with enzyme and NADPH.

  • cShift = (IC50 “minus NADPH”/IC50 “plus NADPH”) ± S.D. of three experiments.

  • dNA, not analyzed.